BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21105635)

  • 1. The impact of multidisciplinary therapy in node-positive rectal cancer.
    Roos M; Wong JH; Roy-Chowdhury S; Lum SS; Morgan JW; Kazanjian AK
    Am Surg; 2010 Oct; 76(10):1163-6. PubMed ID: 21105635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of survival with response to neoadjuvant radiation therapy for rectal cancer.
    Castaldo ET; Parikh AA; Pinson CW; Feurer ID; Merchant NB
    Arch Surg; 2009 Feb; 144(2):129-34; discussion 134-5. PubMed ID: 19221323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of pelvic radiation in stage II rectal cancer: a population-based analysis.
    Kuo I; Wong JH; Roy-Chowdhury S; Lum SS; Morgan JW; Kazanjian K
    Am Surg; 2010 Oct; 76(10):1092-5. PubMed ID: 21105617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis.
    Greene FL; Stewart AK; Norton HJ
    J Clin Oncol; 2004 May; 22(10):1778-84. PubMed ID: 14769855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision?
    Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K
    Am Surg; 1997 Jul; 63(7):579-84; discussion 584-5. PubMed ID: 9202530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.
    Moore HG; Shia J; Klimstra DS; Ruo L; Mazumdar M; Schwartz GK; Minsky BD; Saltz L; Guillem JG
    Ann Surg Oncol; 2004 Nov; 11(11):955-61. PubMed ID: 15525823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.
    Ahmed S; Ahmad I; Zhu T; Arnold FP; Faiz Anan G; Sami A; Yadav SK; Alvi R; Haider K
    Dis Colon Rectum; 2010 Oct; 53(10):1432-8. PubMed ID: 20847626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision.
    Kim YW; Kim NK; Min BS; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2009 Jun; 249(6):965-72. PubMed ID: 19474683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma.
    Gourin CG; Conger BT; Porubsky ES; Sheils WC; Bilodeau PA; Coleman TA
    Laryngoscope; 2008 Jul; 118(7):1191-4. PubMed ID: 18391764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
    Vecchio FM; Valentini V; Minsky BD; Padula GD; Venkatraman ES; Balducci M; Miccichè F; Ricci R; Morganti AG; Gambacorta MA; Maurizi F; Coco C
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):752-60. PubMed ID: 15936556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome.
    Chang GJ; Rodriguez-Bigas MA; Eng C; Skibber JM
    Cancer; 2009 Dec; 115(23):5432-40. PubMed ID: 19673001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of fat clearance lymph node harvest for invasive rectal adenocarcinoma following neoadjuvant therapy.
    Wang H; Safar B; Wexner SD; Denoya P; Berho M
    Dis Colon Rectum; 2009 Oct; 52(10):1767-73. PubMed ID: 19966611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
    Smalley SR; Benedetti JK; Williamson SK; Robertson JM; Estes NC; Maher T; Fisher B; Rich TA; Martenson JA; Kugler JW; Benson AB; Haller DG; Mayer RJ; Atkins JN; Cripps C; Pedersen J; Periman PO; Tanaka MS; Leichman CG; Macdonald JS
    J Clin Oncol; 2006 Aug; 24(22):3542-7. PubMed ID: 16877719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative borderline elevated CEA predicts for earlier relapse in patients with rectal cancer receiving adjuvant postoperative therapy.
    Dawson LA; Franssen E; Davey P
    Cancer J Sci Am; 1999; 5(6):374-9. PubMed ID: 10606480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy.
    Morcos B; Baker B; Al Masri M; Haddad H; Hashem S
    Eur J Surg Oncol; 2010 Apr; 36(4):345-9. PubMed ID: 20071133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracapsular spread of nodal metastasis as a prognostic factor in rectal cancer.
    Heide J; Krüll A; Berger J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):773-8. PubMed ID: 14967433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
    Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
    Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.